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Introduction: Context-specific improvements in the continuum of
HIV care are needed to achieve the UNAIDS target of 90-90-90.
This study aimed to assess the linkage to and retention in HIV care
according to different testing modalities in rural
southern Mozambique.
Methods: Adults newly diagnosed with HIV from voluntary
counseling and testing, provider-initiated counseling and testing,
and home-based HIV testing services were prospectively enrolled
between 2014 and 2015 at the Manhiça District. Patients were
passively followed up through chart examination. Tracing was
performed at 12 months to ascertain causes of loss to follow-up.
Fine and Gray competing risk analysis was performed to determine
factors associated with the each step of the cascade.
Results: Overall linkage to care as defined by having a CD4 count
at 3 months was 43.7% [95% confidence interval (CI): 40.8 to 46.6]
and 25.2% of all participants initiated antiretroviral therapy. Factors
associated with increased linkage in multivariable analysis included
testing at voluntary counseling and testing, older age, having been
previously tested for HIV, owning a cell phone, presenting with
WHO clinical stages III/IV, self-reported illness-associated disability
in the previous month, and later calendar month of participant
recruitment. Ascertaining deaths and transfers allowed for adjust-
ment of the rate of 12-month retention in treatment from 75.6% (95%
CI: 70.2 to 80.5) to 84.2% (95% CI: 79.2 to 88.5).
Conclusions: Home-based HIV testing reached a sociodemographi-
cally distinct population from that of clinic-based testing modalities but
low linkage to care points to a need for facilitated linkage interventions.
Distinguishing between true treatment defaulting and other causes of
loss to follow-up can significantly change indicators of retention in care.
Key Words: HIV, linkage, retention, cascade, sub-Saharan Africa,
Mozambique
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INTRODUCTION
Currently, approximately 30% of people living with
HIV (PLWHIV) worldwide do not know their HIV status.1
Although voluntary counseling and testing (VCT) and clinic-
based provider-initiated counseling and testing (PICT) con-
tinue to be the most widespread HIV counseling and testing
(HCT) strategies worldwide,2 other modalities such as home-
based HIV testing (HBT) or self-testing strategies are gaining
momentum to reach populations that would otherwise be left
behind, such as men or young people.1
Data assessing effectiveness of linkage to HIV care
according to testing modalities are often inconclusive, partially
due to lack of comparability between studies each assessing 1 or
2 testing modalities under distinct study populations, epidemi-
ologic contexts, HIV program implementation conditions, and
outcome definitions.3–7 PLWHIV tested through PICT or VCT
seem to have higher engagement in care compared with those
identified through HBT, who may not show the same motivation
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for accessing health services.7 In a recent systematic review,
linkage to care after HBT was generally low (,33%) but
increased (.80%) if additional linkage strategies were used.8
Regardless of the testing modality, overall linkage and retention
is fraught with obstacles, which contribute to loss to follow-up
(LTFU) at different stages of the continuum of care. A
systematic review in sub-Saharan Africa estimated that only
59%–78% of PLWHIV diagnosed receive a CD4 result within
the first 3 months, 45% of patients are retained in pre-
antiretroviral therapy (ART), and 66% of those eligible initiate
ART.9 Once on ART, a third of patients are reported as LTFU
within 3 years.10 Thus, as countries transition to test and treat,
careful monitoring of the linkage and retention rate as well as
detailed characterization of LTFU will be essential for appro-
priate management and evaluation of cascade-wide trends in
LTFU.11,12
In Mozambique, it is estimated that only 57% of
PLWHIV enroll in care after diagnosis,13 and 3-year ART
retention is 44%.14 However, estimates of LTFU may be
overestimated due to incomplete ascertainment of outcomes.
Active tracing activities to properly identify outcomes such as
silent transfers, deaths, and migration are thus essential to
improve LTFU estimates. This study aimed to assess the
linkage care according to different testing modalities and
secondarily evaluate the retention in HIV care and investigate
factors associated with uptake across the care cascade in rural
southern Mozambique.
MATERIALS AND METHODS
Study Setting and Procedures
The study was performed in the area covered by the
health and demographic surveillance system (HDSS) located
in the Manhiça District, a semirural area with a high HIV
burden of disease in Mozambique.15,16 Further study area
details are provided in the supplemental digital content.
This prospective cohort study consecutively enrolled
patients with a new HIV diagnosis after HCT from trained
counselors through VCT, outpatient PICT, and HBT between
May 2014 and June 2015, before test and treat.17 The cohort
inclusion criteria were adults older than 18 years willing to
participate, resident in the Manhiça District Hospital (MDH)
catchment area, and receiving a first HIV-positive result.
Pregnant and TB co-infected patients who were diagnosed
with HIV at the antenatal clinic or at the TB clinic, followed
a specific model of integrated care and were thus excluded.
Individuals tested through VCT and PICT were screened for
eligibility after receiving an HIV-positive result, whereas in
HBT, patients were screened before testing. For the purpose
of this study, PICT was implemented at the MDH adult triage
clinic as an opt-out strategy. HBT was performed using a list
of adults randomly selected among the residents recorded in
the HDSS. Three attempts were made to contact each
individual before defining the status as absent and replace-
ment was used when household residents could not be found.
All participants with a new HIV diagnosis were referred
to the MDH for enrollment in HIV care. The study procedures
did not influence the linkage to care beyond the HCT and
facility-based guidance to the MDH reception. At 12 months
after diagnosis, patients defaulting at any stage were con-
tacted by field counselors for active tracing to ascertain
outcomes: migration, silent transfer, death, and LTFU.
Data Collection
This study included several data sources: (1) basic
sociodemographic variables and information regarding HCT
were recorded in study-specific forms at the time of testing
and enrollment; and (2) passive follow-up clinical data were
obtained from the MDH HIV electronic patient tracking
system (ePTS).18 The charts of those patients who were
identified as defaulting at any stage of the cascade were
reviewed manually for quality check. For those not enrolled,
we certified the absence of enrollment by matching the study
database to the ePTS based on probabilistic matching
methods19; (3) vital status was extracted from the HDSS;
and (4) 12-month tracing of outcomes were recorded in study-
specific forms at the time of home visits to patients defaulting
at any stage according to data from ePTS and clinical charts.
Outcome Definitions and Statistical
Considerations
The primary outcome was linkage to care, a binary
variable defined as having a first CD4 count available within 3
months of diagnosis. For the purpose of the study and assuming
a 50% linkage to care rate in VCT, a sample size of 408 HIV-
positive individuals in each testing group was estimated to be
necessary to detect a difference of 10% in linkage to care by
PICT or HBT as compared with VCT with 80% power.
Self-reported knowledge of HIV was framed as a yes/
no question as whether the participant knew what HIV was.
Intention to disclose HIV status to partner was also asked as
a yes/no question. Self-reported disability due to illness was
defined as being unable to perform daily activities at least
once in the past month due to illness. Occupation was
categorized as: services, farming, and other, which included
unremunerated activities such as domestic, unemployed,
students, and no information. The history of a previous
negative HIV testing at any time was collected.
The uptake of each of the following steps of the cascade
was measured: (1) enrollment in care, defined as registering at
the MDH and receiving a hospital identification number; (2)
first clinical consultation; (3) linkage to care; and (4) ART
initiation. The study used a 3-month cut-off from diagnosis to
steps 1–3. For step 4, the 3-month cut-off was applied from
the date of ART eligibility to initiation. For the purpose of
this analysis, we only considered ART eligibility and
initiation based on the criteria determined at first clinical
visit. Twelve-month retention on ART was defined as having
a clinical visit in the previous 180 days according to
a proposed conservative universal definition of LTFU in
HIV treatment programs, which corresponds to being at least
90 days late for a clinical visit.20,21 The definition of LTFU
was thus specific for every step and included patients not
uptaking first steps of the cascade plus those LTFU in ART.
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We compared descriptive characteristics using x2 tests for
categorical variables. We used the Fine and Gray competing risk
model, with death being the main competing event, to estimate
the impact of testing modality on each specific step of the
cascade conditioned on the completion of the previous step. The
hazard ratio of the subdistribution was used as a measure of
association together with the corresponding 95% confidence
interval (95% CI). Time was calculated from diagnosis to date
when each step was reached, or date of death. Variables listed in
Table 1 were entered into the models through a backward
stepwise elimination procedure using Wald test P-values of P,
0.2 for addition and P . 0.1 for removal from the model. The
final multivariable models were adjusted for age, sex, testing
modality, as well as later month of study enrollment, defined as
the number of months elapsed between study initiation and
participant recruitment. We found no multicollinearity between
variables or interactions between sex, age, and testing modality.
Ethical Approval
This study was approved by the Mozambican National
Bioethics Committee, Institutional Review Boards at the Centers
for Disease Control and Prevention, Barcelona Institute of
Global Health, and Centro de Investigaçao em Saude de
Manhiça. All participants provided written informed consent.
RESULTS
Study Profile and Population Characteristics
During the study period, 1955 adults tested positive for
HIV at the MDH (VCT and PICT) were approached to
determine their eligibility for the study. Over half did not meet
inclusion criteria and among those eligible, the acceptance rate
was 86.6% and 91.4% in VCT and PICT, respectively (Figs.
1A, B). Of 11,793 individuals randomly selected and confirmed
to reside in the HDSS, 10,897 home visits were performed and
75% (n = 8192) of individuals were found and were screened for
eligibility; among them, 16.3% had a previous HIV diagnosis (n
= 1335) and 1.5% (n = 121) were pregnant and therefore not
eligible (Fig. 1C). A total of 82.2% (n = 6736) of the home visits
fulfilled inclusion criteria and the acceptance rate was 76.0%,
significantly lower than in the clinic modalities (P , 0.001).
Among those tested, 7.2% had a positive HIV result (n = 369).
No prevalent TB cases were identified at the time of recruitment
in any of the three testing modalities.
TABLE 1. Characteristics of Study Population According to Testing Modality
Testing Modality (n, %)
Global PVCT PICT HBT Total
No. enrolled, n 330 423 369 1122
Median age in years (IQR) 32.1 (25.5–40.7) 32.2 (25.7–39.4) 36.2 (28.3–46.1) 33.2 (26.4–42.9) ,0.001
Sex
Male 129 (39.1) 196 (46.3) 168 (45.5) 493 (43.9) 0.105
Female 201 (60.9) 227 (53.7) 201 (54.5) 629 (56.1)
Occupation ,0.001
Services 117 (35.5) 155 (36.6) 165 (44.7) 437 (39.0)
Farming 37 (11.2) 70 (16.6) 104 (28.2) 211 (18.8)
Other 176 (53.3) 198 (46.8) 100 (27.1) 474 (42.2)
Self-reported knowledge of HIV ,0.001
No 24 (7.3) 24 (5.7) 73 (19.8) 121 (10.8)
Yes 306 (92.7) 399 (94.3) 296 (80.2) 1001 (89.2)
Previous HIV-negative test
No 187 (56.7) 243 (57.5) 198 (53.7) 628 (56.0) 0.538
Yes 143 (43.3) 180 (42.6) 171 (46.3) 494 (44.0)
Intention to disclose partner
Has no partner 89 (27.0) 78 (18.4) 57 (15.4) 224 (20.0) 0.002
Intention to disclose partner 216 (64.4) 314 (74.2) 257 (69.6) 787 (70.1)
No intention to disclose partner 25 (7.6) 31 (7.3) 55 (14.9) 111 (9.9)
Testing type
Individual 271 (82.1) 402 (95.0) 340 (92.1) 1013 (90.3) ,0.001
Nonindividual 59 (17.9) 21 (5.0) 29 (7.9) 109 (9.7)
Disability in previous month
No 306 (92.7) 409 (96.7) 339 (91.9) 1054 (93.9)
Yes 24 (7.3) 14 (3.3) 30 (8.1) 68 (6.1) 0.010
Has cell phone
No 66 (20.0) 122 (28.8) 112 (30.4) 300 (26.7) 0.004
Yes 264 (80.0) 301 (71.2) 257 (69.6) 822 (73.3)
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Overall, a total of 1122 adults with a new HIV-positive
result were enrolled from the 3 HIV testing modalities: VCT (n
= 330), PICT (n = 423), and HBT (n = 369). Fifty-six percent
were female and the median age at the time of enrollment was
33 years (Table 1). Baseline characteristics differed between
testing modalities in all variables except for sex (P = 0.105) and
history of negative HIV previous test year (P = 0.538) (Table 1).
Regardless of testing modality, less than half the participants
reported a previous HIV negative test. HBT participants were
slightly older, more likely to be farmers, and fewer self-reported
knowledge on HIV as compared with VCT and PICT (Table 1).
Through VCT, nonindividual testing was significantly more
frequent and participants were more likely to have a cell phone
than in the other modalities. PICT patients were less likely to
report disability in the previous year.
Three-Month Uptake of Care
Individuals in the HBT group showed significantly lower
uptake of enrollment in care [35.5% (95% CI: 30.6 to 40.6)]
compared with the clinic-based testing modalities {[98.5% (95%
CI: 96.5 to 99.5)] and [90.8% (95% CI: 87.6 to 93.4)] in VCT
and PICT, respectively, P , 0.001} (Fig. 2). Overall linkage to
care as defined by having a CD4 count (see methods) was
43.7% (95 CI%: 40.8 to 46.6), and 25.2% of all participants
initiated ART.
The cascade of care conditioned on completion of the
previous step showed that a total of 69.0% of patients linked
(n = 338) were eligible for ART at the initial evaluation visit
according to national guidelines (see Figure 1, Supplemental
Digital Content, http://links.lww.com/QAI/B164). Of those
eligible, 83.7% initiated ART within the following 3 months,
with a median time from diagnosis to ART initiation of 46 days
[interquartile range (IQR): 31–78]. Testing modality was not
associated with WHO stage (P = 0.204), ART eligibility among
linked patients (P = 0.429), or proportion of patients initiating
ART among those eligible (P = 0.124) (see Figure 1,
Supplemental Digital Content, http://links.lww.com/QAI/
B164). Of those linked, median initial CD4 cell count was
291 cells/mm3 (IQR: 173–450), with no significant differences
across groups [VCT: 282 (IQR: 170–427), PICT: 294 (IQR:
155–458), and HBT: 315 (IQR: 178–506), P = 0.570]. Fifteen
percent of participants had CD4 ,100 cells/mm3, and 5.8% of
participants had an advanced WHO stage III/IV at first visit.
Twelve-Month Uptake of Care
We then explored the linkage and retention indicators
conditioned on the previous step of the cascade over the 12
months after diagnosis. Most uptake of enrollment in care and
first clinical visit occurred in the first 3 months after
diagnosis, with only an additional 3.7% and 6.2% subjects
with delayed enrollment or clinical visit, respectively. How-
ever, among individuals with a clinical visit, 20.2% had
a delayed linkage between 3 and 12 months after diagnosis
and 16.6% did not link at all during the first year.
FIGURE 1. Study profile for patients enrolled in the study
through different testing modalities: (A) VCT, (B) PICT,
and (C) HBT. Percentages are calculated over the previous
step.
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Patient home visits were conducted at 12 months,
among patients LTFU at different steps of the cascade. Of
those who had never linked to care, 41.7% were indeed not in
care, whereas of those eligible for ART who had never
initiated, 25% had discontinued and 17.5% had died (Fig. 2).
Among those LTFU in ART, the proportion of deaths reached
21.7%. Thus, the proportion of those with confirmed
discontinuation decreased along the cascade, whereas the
proportion of deaths increased (P , 0.001) (Fig. 3). Of those
who initiated ART, the 12-month retention was 75.6% (95%
CI: 70.2 to 80.5). Patient tracing allowed for adjustment of the
estimate of patients retained on ART at 12 months, taking into
account death and both documented plus silent transfers.
Removing these from the denominators adjusted the estimate
of 12-month retention to 84.2% (95% CI: 79.2 to 88.5).
Determinants of Early Uptake at Each Step of
the Cascade of Care
We identified factors associated with timely uptake of
each step of the cascade. Multivariable analysis showed that
older age, self-reported disability in the previous month due
to illness, having a cell phone, and later calendar month of
participant recruitment were positively associated with enroll-
ment in care at 3 months (Table 2). However, testing modality
(PICT or HBT) as well as self-reported knowledge of HIV
were negatively associated with enrollment in care (Table 2).
The participants from the 3 testing modalities differed in most
of the covariates (Table 1). Confounding of covariates by
testing modality was confirmed using bivariate analysis and
stratified analysis (see Tables 1 and 2, Supplemental Digital
Content, http://links.lww.com/QAI/B164), and only adjusted
values are shown in Table 2.
Among patients who enrolled in HIV care, older age
($45 compared with ,25 years) and later calendar month of
participant recruitment were positively associated with having
a first clinical consultation (Table 2). However, PICT and
HBT as compared with VCT were predictors of not having
a clinical consultation (Fig. 3).
Among patients with a clinical visit, older age, having
a previous negative HIV test, advanced WHO stage, self-
reported disability, having a cell phone, and later calendar
month of participant recruitment were positively associated
with linkage to care at 3 months. Similarly to previous steps
in the cascade, PICT and HBT were both associated with
decreased linkage in multivariate analysis (Table 2).
We did not identify any factors significantly associated
with initiating ART among those eligible (Table 2).
DISCUSSION
These results provide comprehensive estimates from
Mozambique of early engagement in care after HIV diagnosis
using various common testing strategies. Although HBT was
3-fold less efficient at linking patients in care than were the
VCT and PICT modalities, mostly due to a significant block
in the enrollment in HIV care stage, HBT reached a slightly
older population with less self-reported knowledge of HIV. A
home-based tracing study at 12 months allowed for adjust-
ment of estimates of ART retention at 12 months. After
elimination of deaths and transfers misclassified as suspected
LTFU, the estimate of ART retention at 12 months increased
from 75.6% to 84.2%.
Traditional HCT approaches based solely on VCT run
the risk of missing populations who present specific linkage
challenges. HBT reached an older population that was distinct
to the clinic population in all tested variables except for sex
and previous HIV-negative testing history. HBT had an
acceptability rate of 76% and provided a 7.2% yield of
identification of new HIV diagnoses, thus representing an
effective strategy for reaching PLWHIV in a setting of
hyperendemic HIV. However, without additional strategies
that facilitate linkage, 65.5% of patients tested through HBT
were lost at the initial steps of the cascade, similar to
observations in neighboring countries.4,6,22 Being solicited
through a non–client-initiated approach such as HBT when
individuals are healthy could lead to lower motivation to seek
care as opposed to when the same individual voluntarily seeks
contact with the health services and/or feels ill.5,23,24 A recent
model has suggested that facilitated linkage interventions will
be crucial for cost-effectiveness of test and treat particularly
as a larger number of healthier patients initiates treatment.25
In addition to individual factors, health system–driven
variations in patient flow may impact linkage from different
testing modalities. In Manhiça, the VCT occurs early in the
day, allowing for completion of the first 2 steps of enrollment
and clinical visit within the same day. However, in the case of
outpatient PICT, a high volume of patients often leads to
delaying the specific HIV clinical visit until the next day, thus
increasing defaulters at the first step similar to that observed
for HBT. Thus, operational particulars such as simplifying or
collapsing the cascade26 according to HCT modality,
streamlined or accelerated initiation of ART coupled with
community ART initiation, and/or patient-centered differen-
tiated care11 will be key to successful implementation of test
and treat.
FIGURE 2. Three-month uptake of the initial steps of the HIV
care cascade for all new HIV diagnoses according to testing
modality. Uptake of each step is defined at 3 months after
diagnosis for the first 3 steps (enrollment, consultation, and
linkage to care) and 3 months after ART eligibility for the final
step of ART initiation. Each bar represents the proportion of
the total number of individuals recruited (N = 1122).
J Acquir Immune Defic Syndr  Volume 78, Number 5, August 15, 2018 Uptake of HIV Care in Rural Mozambique
Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. www.jaids.com | 531
TABLE 2. Multivariate Analysis of Factors Associated With Each Step of the Cascade
A. Enrollment in Care B. Clinical Consultation
n (%) aSHR 95% CI P n (%) aSHR 95% CI P
Test modality
VCT 325 (98.5) Reference ,0.001 296 (91.1) Reference ,0.001
PICT 384 (90.8) 0.81‡ (0.74 to 0.87) 307 (80.0) 0.65‡ (0.55 to 0.76)
HBT 131 (35.5) 0.13‡ (0.11 to 0.16) 118 (90.1) 0.47‡ (0.40 to 0.55)
Age category
18–24 175 (75.8) Reference ,0.001 145 (82.9) Reference 0.107
25–34 297 (75.0) 1.05 (0.92 to 1.20) 256 (86.2) 1.14 (0.94 to 1.39)
35–44 188 (72.9) 1.16* (1.01 to 1.34) 161 (85.6) 1.18 (0.95 to 1.45)
45- 180 (75.9) 1.33‡ (1.17 to 1.53) 159 (88.3) 1.30* (1.05 to 1.60)
Sex
Male 363 (73.6) Reference 305 (84.0) Reference
Female 477 (75.8) 1.07 (0.97 to 1.18) 416 (87.2) 1.07 (0.94 to 1.23)
Months from study initiation to participant recruitment,
median (IQR)
5.9 (3.5–9.0) 1.01* (1.00 to 1.03) 6.2 (3.6–9.0) 1.07‡ (1.04 to 1.09)
Occupation
Services 319 (73.0) Reference 0.032 273 (85.6)
Farming 149 (70.6) 1.08 (0.95 to 1.23) 126 (84.6)
Other 372 (78.5) 0.92 (0.83 to 1.02) 322 (86.6)
Self-reported knowledge of HIV
No 80 (66.1) Reference 67 (83.8)
Yes 760 (75.9) 0.83* (0.70 to 0.98) 654 (86.1)
Previous HIV-negative test
No 484 (77.1) 415 (85.7)
Yes 356 (72.1) 306 (86.0)
Intention to disclose partner
No partner 185 (82.6) 163 (88.1)
Intention 587 (74.6) 494 (84.2)
No intention 68 (61.3) 64 (94.1)
Testing type
Individual 748 (73.8) 641 (85.7)
Nonindividual 92 (84.4) 80 (87.0)
Disability previous month
No 787 (74.7) Reference 673 (86.5)
Yes 53 (77.9) 1.18* (1.01 to 1.37) 48 (90.6)
Has cell phone
No 205 (68.3) Reference 169 (82.4)
Yes 635 (77.3) 1.15* (1.03 to 1.28) 552 (86.9)
C. Linkage D. ART Initiation
n (%) aSHR 95% CI P n (%) aSHR 95% CI P
Test modality
VCT 205 (69.3) Reference 0.002 117 (83.0) Reference 0.115
PICT 197 (64.2) 0.76* (0.61 to 0.94) 111 (80.4) 0.86 (0.66 to 1.12)
HBT 88 (74.6) 0.62† (0.47 to 0.83) 51 (92.7) 1.19 (0.87 to 1.62)
Age category
18–24 86 (59.3) Reference ,0.001 38 (79.2) Reference 0.329
25–34 173 (67.6) 1.64† (1.19 to 2.26) 99 (80.5) 1.20 (0.82 to 1.76)
35–44 122 (75.8) 2.17‡ (1.56 to 3.01) 76 (85.4) 1.30 (0.89 to 1.91)
45- 109 (68.6) 2.22‡ (1.57 to 3.14) 66 (89.2) 1.43 (0.96 to 2.13)
Sex
Male 209 (68.5) Reference 125 (81.2) Reference
Female 281 (67.6) 1.21 (0.97 to 1.50) 154 (85.6) 1.13 (0.90 to 1.43)
Months from study initiation to participant recruitment,
median (IQR)
7.6 (5.0–9.6) 1.26‡ (1.22 to 1.31) 7.6 (5.0–9.6) 1.00 (0.97 to 1.04)
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We observed that completion of all steps of the cascade
occurred during the first 3 months after diagnosis, with the
exception of linkage. Although having a CD4 count before
ART initiation will no longer be a criterion for ART initiation
in a test-and-treat approach, CD4 results remain a pillar for
management of patients with advanced HIV disease to
prioritize cotrimoxazole prophylaxis and screening for cryp-
tococcal antigen and TB.27,28 At the first clinical assessment,
over two-thirds of patients were ART-eligible based on CD4
criteria and 15% had CD4 counts under 100/mm3. This
population is susceptible to increased mortality in the first
months of ART due to undiagnosed TB, cryptococcus, and
other bacterial infections that can be prevented through
adequate screening and prophylaxis. A delay or absence of
CD4 results at the time of ART initiation jeopardizes
successful treatment of these patients in advanced disease.
A rapid qualitative test for CD4 levels discriminating
advanced HIV could be very useful in these settings.
Enrollment and linkage to care outcomes shared similar
predictors including testing modality, age, disability due to
illness, cell phone ownership, and months between study
initiation and individual patient enrollment. Owning a cell
phone was independently associated with increased enroll-
ment in care and may behave as a proxy of socioeconomic
status.29 Self-reported disability due to illness in the previous
month was positively associated with enrollment and linkage,
likely due to an increased perceived association of illness with
HIV. The number of months elapsed between study initiation
and individual patient enrollment also positively impacted
linkage. This is likely due to improvements in patient flow
occurring progressively over time, particularly in the case of
PICT, which experienced a gradual transition toward same-
day clinic visit and CD4 results. Having a previous HIV-
negative test, self-reported disability due to illness, or later
WHO stage likely reflected an individual’s higher engage-
ment with the health system and/or illness prompting
TABLE 2. (Continued ) Multivariate Analysis of Factors Associated With Each Step of the Cascade
C. Linkage D. ART Initiation
n (%) aSHR 95% CI P n (%) aSHR 95% CI P
Occupation
Services 198 (72.5) Reference 0.162 112 (85.5)
Farming 79 (62.7) 0.75 (0.56 to 1.01) 45 (83.3)
Other 213 (66.2) 0.90 (0.71 to 1.14) 122 (81.9)
Self-reported knowledge of HIV
No 42 (62.7) 22 (88)
Yes 448 (68.5) 257 (83.2)
Previous HIV-negative test
No 257 (61.9) Reference 155 (83.8)
Yes 233 (76.1) 1.43‡ (1.16 to 1.76) 124 (83.2)
Intention to disclose partner
No partner 115 (70.6) 64 (86.5)
Intention 340 (68.8) 194 (82.2)
No intention 35 (54.7) 21 (87.5)
Testing type
Individual 427 (66.6) 246 (84.3)
Nonindividual 63 (78.8) 33 (78.6)
Disability previous month
No 456 (67.8) Reference 259 (83.6)
Yes 34 (70.8) 1.52† (1.12 to 2.07) 20 (83.3)
Has cell phone
No 109 (64.5) Reference 67 (81.7)
Yes 381 (69.0) 1.44† (1.13 to 1.84) 212 (84.1)
WHO stage
I–II 415 (66.4) Reference 212 (83.5)
III–IV 75 (78.9) 1.46† (1.14 to 1.87) 67 (83.8)
Fine and Gray competing risk model analysis estimating determinants of: (A) enrolling in care at 3 months (n = 840) among all participants (n = 1122); (B) having a first clinical
consultation at 3 months (n = 721) among individuals enrolled in care (n = 840); (C) linkage to care at 3 months (n = 490) among individuals with a first clinical visit (n = 721); and (D)
initiating ART 3 months after eligibility (n = 279) among individuals ART-eligible (n = 334).
n (%): number of individuals with uptake of the corresponding step of the cascade and % of the individuals from each category who enroll in care (A), have a first clinical
consultation (B), link to care (C), and initiate ART (D).
Variables included in the multivariable analyses are listed in Table 1, plus WHO Stage. Only aHR for variables retained in the final model are shown.
*Point estimate P-values are shown as P , 0.05.
†Point estimate P-values are shown as P , 0.01.
‡Point estimate P-values are shown as P , 0.001.
aSHR, adjusted subdistribution hazard ratio.
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increased health-seeking. PICT and HBT testing modalities
showed poorer outcomes than VCT in all steps of the cascade.
Other studies have shown clinic30,31 as well as individual
factors including young age,30,32–34 male sex,35–37 occupa-
tion,33,37 and absence of cell phone34 to be associated with
lower completion of each step of the cascade. Once linked to
care, 83.7% of those eligible initiated ART within 3 months
with a 75.6% 12-month ART retention. These results fall
within the average estimates of ART retention in Southern
Africa, which hover at 76%–65% at 1 and 3 years, respec-
tively.10,38 However, there is great heterogeneity in retention
rates between African subregions39–42 and most estimates
suffer from biases due to incomplete ascertainment of out-
comes. The few published patient-tracing studies estimate that
20%–60% of patients considered LTFU after ART initiation
are likely to have died.12,43 We observed a steady increase in
proportion of LTFU attributable to deaths, which could be due
to a longer accrual of person-time between steps later in the
cascade and highlights the importance of ascertainment of
outcomes. Half the patients considered LTFU in ART care
were either deaths, transfers, or migrations. Ascertaining the
cause of LTFU allowed for an adjustment of the estimated
proportion of 12-month retention from 75.6% to 84.2%.
Precision in LTFU, retention, and mortality indicators is key
for appropriate forecasting and resource allocation in ART
scale-up efforts.12
Implementation research suffers from several limita-
tions. First, linkage to care is based on available electronic
patient data, which may overestimate attrition due to poor
record keeping, even in the context of previous validation of
the accuracy of the databases.5,42,44 We attempted to mitigate
this bias by reviewing paper-based charts and conducting
home visits for patients considered LTFU. Second, although
we only performed the study in the catchment area of the
MDH, it is possible that certain patients prefer to seek for care
at an outside health unit, potentially underestimating the
uptake of care. This is unlikely because the 5% transfer rate
detected through the 12-month visit among participants not
linking to care suggests very little usage of other health
facilities. Third, this study evaluated factors potentially
associated with the uptake of each step. However, we cannot
rule out a residual effect due to potential confounders such as
distance from health care facility, education, marital status,
comorbidities, or other facility-level factors that were not
assessed. Moreover, the framing of the baseline question
“self-reported knowledge of HIV” did not allow us to draw
conclusions on the gaps in understanding of HIV-related
topics in the community and the heterogeneity in occupation
categories did not allow us to draw conclusions. Finally, we
did not detect factors associated with ART initiation, but due
to high participant defaulting before this step, we did not have
the statistical power to detect minor to moderate associations.
CONCLUSIONS
HBT reached a sociodemographically distinct popula-
tion in need of facilitated linkage interventions such as SMS
reminders or patient navigators. Regardless of testing modal-
ity, there is a considerable block in various steps of the early
cascade of care leading to low rates of ART initiation among
newly diagnosed patients, which could potentially limit the
public health benefits of a universal testing and treatment
approach. In addition, weaknesses in distinguishing LTFU
from migrations and silent transfers may cloud accurate
estimations of programmatic indicators.
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